ICCC
ImmuCell Corporation
9.80$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +39.0% | -209.9% | – | – | +1.8% | -173.8% | – | +640.5% | -15.5% | – | |
| – | – | – | +0.6% | +0.6% | +1.5% | -1.3% | -1.1% | +1.6% | +4.0% | -25.2% | -10.9% | – | |
| – | – | – | +20.8% | -20.9% | -11.2% | -24.2% | +27.8% | +9.7% | +41.9% | +32.9% | +73.9% | – | |
| – | – | – | +903.3% | -148.9% | – | – | – | -515.0% | – | – | -52.4% | – | |
| – | -100.0% | – | +57.4% | -20.2% | +121.9% | +67.7% | -52.8% | +282.8% | -71.0% | +2.9% | +314.1% | – | |
| – | – | – | +51.0% | -16.8% | +121.9% | +67.7% | -61.7% | +370.1% | -71.7% | 0.0% | +338.9% | – | |
| – | – | – | – | – | +1.6% | +1.6% | +0.4% | -15.3% | +22.1% | +1.4% | +0.6% | – | |
| – | – | – | -69.6% | – | -95.4% | -371.1% | -81.1% | +341.7% | +16.9% | +1.4% | -40.6% | – | |
| – | – | – | – | +582.6% | -102.0% | – | +66.3% | -251.0% | – | – | -31.9% | – | |
| – | – | – | +35.3% | -254.5% | – | – | +16.2% | -222.8% | – | +994.6% | -32.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.